Arthritis Research UK’s on-going partnership with NHS England to co-fund the piloting of a patient reported outcome measure (PROM) within the NHS has progressed into clinical testing. The name of the tool, which in its draft format was known as the M-PROM, has now changed to the ‘Arthritis Research UK MusculoSkeletal Health Questionnaire’, abbreviated as ‘MSK-HQ’.
As people with musculoskeletal conditions are treated at inpatient, outpatient and community settings, the work will seek to understand how the MSK-HQ can be used in these settings, by people with different musculoskeletal conditions, and the value brought by using it. This phase of the work will address clinical pathways for orthopaedic surgery, physiotherapy, and early inflammatory arthritis, and a fourth strand will look at the implementation of the MSK-HQ across a whole health economy as part of commissioning. The work on the second phase will continue to be led by the research teams at Oxford University and the Arthritis Research UK Primary Care Centre at Keele. For more information please contact Einan Snir, Health Data Analyst: email@example.com